Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 701–800 of 1,000
Fox, S., Ryan, K. A., Berger, A. H., Petro, K., Das, S., Crowe, S. E., & Ernst, P. B. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0098-8 · Cited by 10
“one of the most common infections worldwide [1–3].”
BackgroundLee, H., Su, Y., Huang, B., Hsieh, F., Chang, Y.-H., Tzeng, S., Hsu, C., Huang, P., Lou, K., Wang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep37367 · Cited by 10
Song, Z., Zhang, T., Li, G., Tang, Y., Luo, Y., & Yu, G. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.002 · Cited by 10
Helicobacter pylori Induces Activation of Human Peripheral γδ+ T Lymphocytes
Romi, B., Soldaini, E., Pancotto, L., Castellino, F., Giudice, G. D., & Schiavetti, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019324 · Cited by 10
“Chronic infection with Helicobacter pylori is the major known risk factor for duodenal and gastric ulcer diseases and cancer [1,2], which are frequently associated with the expression of CagA antigen [3,4,5].”
BackgroundVaccination with Helicobacter pylori attachment proteins protects against gastric cancerPreprint
Bugaytsova, J. A., Piddubnyi, A., Tkachenko, I., Rakhimova, L., Edlund, J. O., Thorell, K., Marcotte, H., Lundquist, A., Schön, K., Lycke, N. Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.25.542131 · Cited by 10
“and (3) that the pre-challenge titer results suggest that the IT50 test of a blood sample 14”
Lu, W., Aihaiti, A., Abudukeranmu, P., Liu, Y., & Gao, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05320-6 · Cited by 9
“For instance, the association between Helicobacter pylori ( H. pylori ) infection and gastric cancer (GC) exemplifies the significant impact of certain intratumoral bacteria on the onset of digestive system malignancies [64].”
BackgroundDevelop a circular RNA–related regulatory network associated with prognosis of gastric cancer
Wei, S., Teng, S., Yao, J., Gao, W., Zang, J., Wang, G., & Hu, Z. (2020) · Cancer Medicine · doi:10.1002/cam4.3035 · Cited by 9
Small Animals Gut Microbiome and Its Relationship with Cancer
Ferrarias, T. M., & Santos, A. A. F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95780 · Cited by 9
Genomics and epidemiology for gastric adenocarcinomas
GE4GAC group (2017) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-017-0011-2 · Cited by 9
“This is followed by the replacement of the normal glandular architecture by an intestinal-type metaplastic mucosa sometimes with the progressive development of cellular atypia (dysplasia), which culminate with GAC [29].”
BackgroundMalespín-Bendaña, W., Ferreira, R. M., Pinto, M. T., Figueiredo, C., Alpízar‐Alpízar, W., Une, C., Figueroa-Protti, L., & Ramírez, V. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-00940-4 · Cited by 9
Mohiuddin, M., Keka, I. S., Evans, T. J., Hirota, K., Shimizu, H., Kono, K., Takeda, S., & Hirano, S. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1084-7 · Cited by 10
Lü, L., Zeng, H., Pi-long, W., Shen, W., Xiang, T., & Mei, Z. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05306-11 · Cited by 9
“It causes a chronic low-level inflammation of the stomach lining and is strongly linked to the development of gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer (23, 25, 28, 31).”
BackgroundHeat Shock Factor 1 as a Prognostic and Diagnostic Biomarker of Gastric Cancer
Kim, W., & Kim, S. (2021) · Biomedicines · doi:10.3390/biomedicines9060586 · Cited by 9
Stimulus-responsive biomaterials for Helicobacter pylori eradication
Shan, T., Chen, X., Zhou, X., Wang, N., Ren, B., & Cheng, L. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.12.019 · Cited by 9
Li, K., Dan, Z., Hu, X., Ouzhu, M., Ciren, Y., Wang, Z., Wang, J., Yang, X., & Ze, Y. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1559-0 · Cited by 9
“pylori is *75 % [5, 6].”
Lysyl Oxidase Isoforms in Gastric Cancer
Añazco, C. C., Delgado‐López, F., Araya, P., González, I., Morales, E., Pérez-Castro, R., Romero, J. A., & Rojas, A. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0075 · Cited by 9
Lam, W., Sun, K., Zhang, H., & Au, S. W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00787 · Cited by 10
Helicobacter pylori Prevalence in Laparoscopic Sleeve Gastrectomy Specimen
Sabbah, N., Saoud, C., Deeb, M. E., & Nasser, S. M. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/8843696 · Cited by 9
“postoperative complications [9, 17, 18, 20], this microorganism is a well-established major etiological agent for peptic ulcer disease and gastric cancer [25, 26] and has been associated with the development of intestinal metaplasia that carries a potential risk for malignancy [27, 28].”
BackgroundWang, X., Ling, F., Wang, H., Yu, M., Zhu, H., Chen, C., Qian, J., Liu, C. X., Zhang, Y., & Shao, S. (2016) · Current Microbiology · doi:10.1007/s00284-016-1016-x · Cited by 9
“peptic ulcers in approximately 10–20 %, and gastric adenocarcinomas in 1 % of those it infects [3, 14, 26].”
BackgroundResistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells
Jiang, R., Zhao, C., Wang, X., Wang, S., Sun, X., Tian, Y., & Song, W. (2016) · Medical Science Monitor · doi:10.12659/msm.895598 · Cited by 9
A Synthesis of Exiguaquinol Dessulfate
Schwarzwalder, G. M., Scott, D. R., & Vanderwal, C. D. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604506 · Cited by 9
Tran, V. T. A., Etemadi, N., Tran, M., Lee, J., Ko, H. S., Jo, D., Lee, L. P., & Cho, H. (2025) · BioChip Journal · doi:10.1007/s13206-025-00203-4 · Cited by 8
“Helicobacter pylori , abbreviated as HP, a prominent patho-gen in the gastrointestinal (GI) tract, affects over 50% of the world’s population [1] and contributes significantly to the onset of gastric inflammation and cancer [2].”
Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk
Buzhor, M. G., Longobardi, G., Kandli, O., Krinsky, A., Avramoff, O., Katyal, A., Salomon, K., Miari, A., Venkert, D., Barnatan, T. T., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503198 · Cited by 12
Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer
Cao, R., Zhou, F., Zhu, C., & Xu, H. (2025) · Gastric Cancer · doi:10.1007/s10120-025-01675-x · Cited by 11
“Alongside CagA, the VacA toxin secreted by H. pylori plays a critical role in the development of GC. VacA induces vacuolization within gastric epithelial cells, triggering apoptosis [21].”
Setting higher standards for reports of microbial species in human cancers
Salzberg, S. L., Chia, M., Tay, C. Y., de Miranda, N. F. C. C., Smit, V. T. H. B. M., Wesseling, J., Irizarry, R. A., Marshall, B. J., Willerslev, E., Neefjes, J., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01121-6 · Cited by 8
Zhou, T., Meng, X., Wang, D., Fu, W., & Li, X. (2022) · Disease Markers · doi:10.1155/2022/9584507 · Cited by 8
Kuete, V. (2022) · Advances in botanical research · doi:10.1016/bs.abr.2022.08.022 · Cited by 9
Saberi, S., Esmaeili, M., Saghiri, R., Shekari, F., & Mohammadi, M. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106024 · Cited by 8
Park, J. H., Cho, H. J., Seo, J., Park, K. B., Kwon, Y. H., Bae, H. I., Seo, A. N., & Kim, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-45930-6 · Cited by 8
Li, B., He, J., Zhang, R., Liu, S., Zhang, X., Li, Z., Ma, C., Wang, W., Cui, Y., & Zhang, Y. (2024) · Helicobacter · doi:10.1111/hel.13109 · Cited by 8
“Despite being recognized as the most significant risk factor for gastric cancer, only a few individuals with H. pylori colonization will actually develop gastric cancer [27].”
Xia, C., Chen, Z., Chen, Y., Wei, F., Wu, S., Zhou, Q., Li, P., & Gu, Q. (2024) · Helicobacter · doi:10.1111/hel.13130 · Cited by 8
Graterón, E. E., Ortiz, D., Figueredo, S. A. C., & Porro, M. E. C. (2015) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2015.11.019 · Cited by 8
“differs from babA and cagA genes that are related to more severe ailments in patients where these strains are involved, even making prone to stomach cancer and allergic diseases such as asthma, atopy, eczema and allergic rhinitis [25–28].”
BackgroundNdhlovu, D. N., & Masika, P. J. (2017) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v14i2.28 · Cited by 9
Moayedi, S., Yadegar, A., Balalaie, S., Yarmohammadi, M. E., Zali, M. R., Suzuki, H., Fricker, G., & Haririan, I. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s255611 · Cited by 8
Microbiome and gastrointestinal malignancies
Sayed, I. M., Ramadan, H. K., El‐Mokhtar, M. A., & Abdel-Wahid, L. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.06.005 · Cited by 10
Antani, J. D., Shaji, A., Gupta, R., & Lele, P. P. (2023) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100722-114625 · Cited by 8
Bali, P., Lozano‐Pope, I., Hernandez, J. M., Estrada, M. V., Corr, M., Turner, M. A., Bouvet, M., Benner, C. W., & Obonyo, M. (2024) · iScience · doi:10.1016/j.isci.2024.109457 · Cited by 8
“43 Thus, there is a possibility that some of the gastric cancer patients in our study may not have been H.pylori positive.”
BackgroundÅberg, A., Gideonsson, P., Bhat, A., Ghosh, P., & Arnqvist, A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae188 · Cited by 9
“Helicobacter pylori persistently colonizes the human stomach, which increases the risk for developing peptic ulceration and gastric cancer in a significant part of the world’s population ( 1 ,2 ).”
Effects of Helicobacter Pylori Infection on MUC5AC Protein Expression in Gastric Cancer
Shi, D., Qiu, X.-M., & Bao, Y.-F. (2012) · Future Oncology · doi:10.2217/fon.12.172 · Cited by 8
Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo
Crabtree, J., Jeremy, A. H. T., Duval, C., Dixon, M. F., Danjo, K., Carr, I., Pritchard, D. M., & Robinson, P. A. (2013) · Pathogens · doi:10.3390/pathogens2040571 · Cited by 9
“Infection with the gastric bacterium Helicobacter pylori is associated with increased risk of developing distal gastric cancer [1,2].”
BackgroundArdisson, J. S., Gonçalves, R. D. C. R., Rodrigues, R. P., & Kitagawa, R. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.098 · Cited by 8
Kim, K. H., Park, J., Cho, Y., Cho, S. Y., Lee, B., Jeong, H., Lee, Y., Yi, J., Oh, Y., Lee, J.-J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.09.008 · Cited by 8
“Helicobacter pylori is a well-known risk factor for gastric cancer and could cause chronic infectionon themucosal layer of the stomach.(32) To test whether GMs of the stomach of Hdc mice can properly address H pylori infection, murineadapted H pylori–sydney strain 1 (SS1) was labeled with the green fluorescent carboxy…”
MethodIs there an unrecognised role for Campylobacter infections in (chronic) inflammatory diseases?
Louwen, R., & Hays, J. P. (2013) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 10
Helicobacter pyloriactivation of PARP-1: Usurping a versatile regulator of host cellular health
Nossa, C. W., & Blanke, S. R. (2010) · Gut Microbes · doi:10.4161/gmic.1.6.13572 · Cited by 8
“However, persistent infection with Helicobacter pylori is a wellestablished risk factor for the development of serious gastric disease in humans, including stomach cancer, which is the second leading cause of cancer-related death worldwide.(3) Thus, there is considerable interest in identifying the molecular mechanism…”
BackgroundErratum: Helicobacter Pylori: gastric cancer and beyond
Polk, D. B., & Peek, R. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2903 · Cited by 8
Self-citationLowe, M. S., & Peek, R. M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1691080 · Cited by 7
“As most H. pylori-infected persons do not develop cancer, these data suggest that interactions between H. pylori and other microbial species may influence oncogenesis (Polk and Peek, 2010; Shen et al., 2022).”
Self-citationLee, C., Wu, C., Chang, W., Yang, E., Hsieh, M., Chen, W., Sheu, B., & Cheng, H. (2023) · Helicobacter · doi:10.1111/hel.13033 · Cited by 8
Washington, M. K., & Peek, R. M. (2008) · Wiley eBooks · doi:10.1002/9781444303254.ch42 · Cited by 7
Self-citationGenetic Evolution of aHelicobacter pyloriAcid-Sensing Histidine Kinase and Gastric Disease
Krishna, U. S., Romero–Gallo, J., Suárez, G., Azah, A. M., Krezel, A. M., Varga, M. G., Forsyth, M. H., & Peek, R. M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw189 · Cited by 7
“For example, BabA is an outer membrane protein encoded by the babA2 gene, which binds to fucosylated Lewis antigen on the surface of gastric epithelial cells [2, 3].”
BackgroundSelf-citationSom, S., Banik, G. D., Maity, A., Ghosh, C., Chaudhuri, S., & Pradhan, M. (2018) · Isotopes in Environmental and Health Studies · doi:10.1080/10256016.2018.1467414 · Cited by 7
Wang, J., & Liu, X. (2018) · PubMed Central · Cited by 7
Mahant, S., Chakraborty, A., Som, A., Mehra, S., Das, K., Mukhopadhyay, A. K., Gehlot, V., Bose, S. K., & Das, R. (2021) · Current Microbiology · doi:10.1007/s00284-021-02626-2 · Cited by 8
Chen, Y., Tang, Z., Fu, L., Liu, R., Yang, L., & Wang, B. (2022) · Infection and Immunity · doi:10.1128/iai.00393-22 · Cited by 7
“esses of gastric epithelial cells and promote cell injury and carcinogenesis (34, 35).”
BackgroundMa, L., Liu, Y., Wang, Y., Yang, J., Lu, J., Feng, H., Ye, S., & Liu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212692 · Cited by 7
Azizimoghaddam, Y., Kermanpour, S., Mirzaei, N., Houri, H., Nabavi-Rad, A., Aghdaei, H. A., Yadegar, A., & Zali, M. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-37392-7 · Cited by 7
Ruiz-Fresneda, M. Á., Gijón, A., & Morales-Álvarez, P. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28576-9 · Cited by 9
Saxena, K., Deshwal, A., Pudake, R. N., Jain, U., & Tripathi, R. M. (2023) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0316 · Cited by 7
Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria
Liu, Z., Ma, Y., Ye, J.-X., Li, G., Kang, X., Xie, W., & Wang, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb02362a · Cited by 7
Extracellular Vesicle miRNAs in Diagnostics of Gastric Cancer
Skryabin, G. O., Beliaeva, A. A., Enikeev, A. D., & Tchevkina, E. M. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924070058 · Cited by 7
“Helicobacter pylori infection is one of the main factors provoking GC. Approximately 75% all cases of gastric adenocarcinoma are H. pylori -associated [9]; more than 90% cases of the intestinal GC subtype are H. pylori - positive [10].”
An integrated strain-level analytic pipeline utilizing longitudinal metagenomic data
Zhou, B., Wang, C., Putzel, G., Hu, J., Liu, M., Wu, F., Chen, Y., Pironti, A., & Li, H. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01431-24 · Cited by 8
“Although H. pylori -induced gastritis plays an essential role in gastric cancer initiation, only about 3% infected individuals develop malignancy (Ernst et al. 2006; Polk and Peek 2010).”
BackgroundAmin, M., Shayesteh, A. A., & Serajian, A. (2019) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i3.1315 · Cited by 7
“Virulence factors are used as an important tool in determining the clinical outcomes of the disease (11, 12).”
BackgroundMethodGhayemia, S. M., Aboutaleb, N., Yousefi, G., Mousavi-Niri, N., & Naseroleslami, M. (2022) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.36.96 · Cited by 7
“pylori-infected populations are more likely to develop gastric carcinoma (32).”
BackgroundXu, R., Yang, L., Zhang, Z., Liao, Y., Yu, Y., Zhou, D., Li, J., Guan, H., & Xiao, W. L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1079470 · Cited by 7
Spectrum of gastric malignancy on 18F-FDG PET/CT: a pictorial essay
Makis, W., Ciarallo, A., Hickeson, M. P., Rush, C., Derbekyan, V. A., Novales-Diaz, J. A., Laufer, J., Stern, J., & Lisbona, R. (2012) · Clinical Imaging · doi:10.1016/j.clinimag.2011.12.014 · Cited by 7
Is Helicobacter pylori Always a "Bad Guy"?
Hojsak, I., & Kolaček, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660725 · Cited by 7
“Furthermore, the carcinogenic risk is modified by strainspecific bacterial factors and host responses [37].”
BackgroundMDR-1, Bcl-xL, H. pylori, and Wnt/β-catenin signalling in the adult stomach: how much is too much?
Macleod, J. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.151 · Cited by 10
Zhao, J., Zheng, Z. P., Song, G., Wang, J., Wang, C., Ma, H., Yu, X., Sui, A., & Zhang, H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2333 · Cited by 7
Javadi, M. B., & Katzenmeier, G. (2016) · Current Microbiology · doi:10.1007/s00284-016-1141-6 · Cited by 7
“Helicobacter pylori is a human-specific Gram-negative pathogenic bacterium that survives within the gastric mucosal layer in the stomach causing a number of severe and chronic diseases [3, 4, 34].”
BackgroundFialho, A., Fialho, A. B. C., Nassri, A. B., Muenyi, V., Malespin, M. H., Shen, B., & de Melo, S. W., Jr. (2019) · Cureus · doi:10.7759/cureus.6226 · Cited by 7
“Introduction Helicobacter pylori (HP) is a Gram-negative bacterium that colonizes the gastric epithelium and is the most common bacterial infection worldwide, infecting approximately half of the world’s population [1].”
BackgroundMethylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers
Tran, M. T. M. T., Yeh, K., Chuang, Y., Hsu, P., Low, J.-T., Kumari, H., Lee, Y.-T., Chen, Y.-C., Huang, W.-H., Jin, H., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250499 · Cited by 7
“pylori), a gram-negative bacteria, is an important risk factor for gastric cancer [2].”
BackgroundEpstein-Barr virus associated gastric dysplasia: a new rare entity?
Angerilli, V., Galuppini, F., Pennelli, G., Fanelli, G. N., dʼAmore, E. S. G., Michelotto, M., Pilati, P., Spolverato, G., Pucciarelli, S., Scarpa, M., et al. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03206-2 · Cited by 7
Peretz, A., Paritsky, M., Pastukh, N., Koifman, A., Brodsky, D., Glyatman, T., & On, A. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000054 · Cited by 7
“…have been developed to cultivate this human pathogen; some include different growth media – solid or liquid – and a range of protocols that, among others, call for the use of an automated system for successful bacterial culturing (Hachem et al., 1995; Peretz et al., 2013; Sainsus et al., 2008).”
BackgroundRegulation of p53 by Helicobacter pylori
Zaika, A. I., Wei, J., Noto, J. M., & Peek, R. M. (2012) · Oncotarget · doi:10.18632/oncotarget.698 · Cited by 8
Self-citationGeng, L., Fan, Z., Chen, R., Cho, K.-C., Liu, Y., Cheng, Y., Yang, J., Zhang, Y., Wei, X., Gong, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116126 · Cited by 6
Li, J., Song, X., Huang, S., Hu, Y., Wang, H., Wang, R., Zhang, Y., Zhang, Y., & Zhang, X. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501197 · Cited by 6
Cáncer gástrico: historia de la enfermedad y factores de riesgo
Pérez‐Cala, T. L., Cardona-Estepa, A., & Martínez, A. (2022) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.372 · Cited by 11
Kos, M., Bojarski, K., Mertowska, P., Mertowski, S., Tomaka, P., Dziki, Ł. A., & Grywalska, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179264 · Cited by 6
Talebi, G., Saffarian, P., Hakemi-Vala, M., Sadeghi, A., & Yadegar, A. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2024.2418494 · Cited by 7
“However, long-term infection has been associated with various gastroduodenal diseases such as chronic atrophic gastritis, peptic ulcer, and gastric malignancies (Polk and Peek Jr 2010).”
Zeng, Z., Jiang, J., Sun, Y., Li, W., Zheng, D., Lin, H.-X., & Zhao, C. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123415 · Cited by 6
PLCε1: A potential target of RNA interference therapy for gastric cancer
Fang, Y., & Fu, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.119 · Cited by 6
Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer
Pant, N., Rakshit, S., Paul, S., & Saha, I. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103254 · Cited by 6
Genetic and molecular biology of gastric cancer among Iranian patients: an update
Abbaszadegan, M. R., Mojarrad, M., Rahimi, H. R., & Moghbeli, M. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00232-w · Cited by 6
Liu, Y., Ma, Y., & Huang, C. (2022) · Chinese Medical Sciences Journal · doi:10.24920/003889 · Cited by 7
Roy, R., Jonniya, N. A., Sk, M. F., & Kar, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.852895 · Cited by 31
“It is a Gram-negative, microaerophilic, spiral bacteria that has been identified as a major etiological factor in gastritis, gastric and duodenal ulcers, gastric adenocarcinoma, and gastric-mucosa-associated lymphoid tissue (MALT) lymphoma (Schreiber et al., 2004; Polk and Peek, 2010).”
BackgroundPopulation Diversity of Leptosphaeria maculans in Australia
Patel, D. A., Zander, M., de Wouw, A. P. V., Mason, A. S., Edwards, D., & Batley, J. (2015) · International Journal of Biology · doi:10.5539/ijb.v7n3p18 · Cited by 6
Zhao, Y., Luo, Y., Huang, B., Qin, B., Zhang, T., Zhang, J., Gu, X., Zheng, G., & Zheng, Z. (2013) · Tumor Biology · doi:10.1007/s13277-013-0706-2 · Cited by 6
“To find more effective measures for both treatment and prevention, we need have a good knowledge of the possible mechanisms of gastric carcinogenesis [5].”
BackgroundShahraki, P. K., Alavianmehr, A., & Farjadian, S. (2018) · Asian Pacific Journal of Cancer Biology · doi:10.31557/apjcb.2018.3.2.37-45 · Cited by 6
“The risk of malignancy is highly related to both bacterial strain and host responses [87].”
BackgroundDifferentiation of H. pylori-negative and positive gastric cancer via regulatory network analysis.
Abdi, S., Azodi, M. Z., Rezaei–Tavirani, M., Razzaghi, M. R., Heidari, M. H., & Baghban, A. A. (2020) · Gastroenterology and hepatology from bed to bench. · Cited by 6
Methylation-Based Signatures for Gastroesophageal Tumor Classification
Alabi, N., Sheka, D., Siddiqui, A., & Wang, E. (2020) · Cancers · doi:10.3390/cancers12051208 · Cited by 6
“Today, the eighth edition of the Union for International Cancer Control-American Joint Committee on Cancer (UICC-AJCC) classification system associates gastroesophageal tumors and esophageal tumors within the same group [1,4].”
BackgroundHelicobacter pylori and gastric cancer
Živković‐Perišić, S. (2020) · Hospital Pharmacology - International Multidisciplinary Journal · doi:10.5937/hpimj2003954z · Cited by 6
Heffley, J. D., & Zubarik, R. S. (2021) · Helicobacter · doi:10.1111/hel.12800 · Cited by 6
Wang, C., Wang, J., Liu, Y., Guo, X., & Zhang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098327 · Cited by 6
Okamoto, T., Hayashi, Y., Mizuno, H., Yanai, H., Nishikawa, J., Nakazawa, T., Iizasa, H., Jinushi, M., Sakaida, I., & Yoshiyama, H. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.09.007 · Cited by 8
“pylori) colonizes approximately half of the world’s population and causes chronic gastritis, peptic ulcers, and gastric adenocarcinoma [1].”
BackgroundInui, I., Mochizuki, S., NISHIMUTA, F., Nagai‐Yoshioka, Y., Takahashi, O., Sasaguri, M., Habu, M., Ariyoshi, W., & Yamasaki, R. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1524820 · Cited by 6
“Helicobacter pylori has been found to cause gastric cancer (Polk and Peek, 2010); since this discovery, studies have also focused on the involvement of speci fi c microorganisms in cancer development.”
Wang, Y., Bi, J., Song, S., Sun, Y. H., & Gong, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1602191 · Cited by 5
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential
He, J., Tan, H. Z., Qiu, Y., Dan, Y., Wan, Q., Li, L., Wu, J., Song, Q., Chen, H., & Xu, B. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101963 · Cited by 5
“6,7 Conversely, other microbes, such as Bifidobacterium , can act as “guardians” by activating anti-tumor immune responses and enhancing the efficacy of treatments like immune checkpoint inhibitors (ICIs).”
Unveiling hidden players: the role of intratumoral microbiota in gastrointestinal cancer dynamics
Tang, W., Li, F., Zheng, H., Zhou, S., Li, C., Xu, X., & Fu, J. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06401-9 · Cited by 5
“As these technologies mature and become more widely cytokines such as IL-1β, IL-6, IL-8, and TNF-α (Polk and Peek 2010 ).”
InfluentialMaddah, R., Molavi, Z., Ehymayed, H. M., Miri, F., Shariati, P., & Veisi, M. (2023) · Human Gene · doi:10.1016/j.humgen.2023.201237 · Cited by 6
Characterization of the gut microbiota and fecal metabolome in the osteosarcoma mouse model
Li, Y., Qiao, X., Feng, Y., Zhou, R., Zhang, K., Pan, Y., Yan, T., Yan, L., Yang, S., Wei, X., et al. (2024) · Aging · doi:10.18632/aging.205951 · Cited by 5
“Recent studies have demonstrated that Helicobacter pylori is a risk factor for gastric cancer [12].”
ResultYang, C., Lü, D., Zhang, X., Li, Y., Zhao, M., & Yang, Y. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107386 · Cited by 5
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.